Written Question·Department of Health and Social Care·UIN HL5291
Tabled: 12 November 2026
Question
To ask His Majesty's Government what assessment they have made of the progress the National Institute for Health and Care Excellent have made towards licensing Omaveloxolone for use in the NHS to treat Friedreich’s Ataxia.